Concourse Financial Group Securities, Inc. Options Holdings

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
Accuray Inc
PUT
$0
0
Q3 2024
New holding
Acelrx Pharmaceuticals Inc
CALL
$0
0
Q3 2024
New holding
Acelrx Pharmaceuticals Inc
PUT
$0
0
Q3 2024
New holding
Acelyrin Inc
CALL
$0
0
Q3 2024
New holding
Acelyrin Inc
PUT
$0
0
Q3 2024
New holding
Achieve Life Sciences Inc
CALL
$0
0
Q3 2024
New holding
Achieve Life Sciences Inc
PUT
$0
0
Q3 2024
New holding
Aci Worldwide Inc
CALL
$0
0
Q3 2024
New holding
Aci Worldwide Inc
PUT
$0
0
Q3 2024
New holding
Aclaris Therapeutics Inc
CALL
$0
0
Q3 2024
New holding
Acm Research Inc
CALL
$0
0
Q3 2024
New holding
Acm Research Inc
PUT
$0
0
Q3 2024
New holding
Acnb Corp
CALL
$0
0
Q3 2024
New holding
Acnb Corp
PUT
$0
0
Q3 2024
New holding
Acorda Therapeutics Inc
CALL
$0
0
Q3 2024
New holding
Acorda Therapeutics Inc
PUT
$0
0
Q3 2024
New holding
Acres Commercial Realty Corp
CALL
$0
0
Q3 2024
New holding
Acres Commercial Realty Corp
PUT
$0
0
Q3 2024
New holding
Actinium Pharmaceuticals Inc
CALL
$0
0
Q3 2024
New holding
Actinium Pharmaceuticals Inc
PUT
$0
0
Q3 2024
New holding
Acuity Brands Inc
CALL
$0
0
Q3 2024
New holding
Acuity Brands Inc
PUT
$0
0
Q3 2024
New holding
Acumen Pharmaceuticals Inc
CALL
$0
0
Q3 2024
New holding
Acumen Pharmaceuticals Inc
PUT
$0
0
Q3 2024
New holding
Acurx Pharmaceuticals Inc
CALL
$0
0
Q3 2024
New holding
Acurx Pharmaceuticals Inc
PUT
$0
0
Q3 2024
New holding
Acushnet Holdings Corp
CALL
$0
0
Q3 2024
New holding
Acushnet Holdings Corp
PUT
$0
0
Q3 2024
New holding
Acv Auctions Inc
CALL
$0
0
Q3 2024
New holding
Acv Auctions Inc
PUT
$0
0
Q3 2024
New holding
Adagio Therapeutics Inc
CALL
$0
0
Q3 2024
New holding
Adagio Therapeutics Inc
PUT
$0
0
Q3 2024
New holding
Adam Nat Res Fd Inc
CALL
$0
0
Q3 2024
New holding
Adam Nat Res Fd Inc
PUT
$0
0
Q3 2024
New holding
Adapthealth Corp
CALL
$0
0
Q3 2024
New holding
Adapthealth Corp
PUT
$0
0
Q3 2024
New holding
Adaptimmune Therapeutics PLC
CALL
$0
0
Q3 2024
New holding
Adaptimmune Therapeutics PLC
PUT
$0
0
Q3 2024
New holding
Adaptive Biotechnologies Cor
CALL
$0
0
Q3 2024
New holding
Adaptive Biotechnologies Cor
PUT
$0
0
Q3 2024
New holding
Adc Therapeutics Sa
CALL
$0
0
Q3 2024
New holding
Adc Therapeutics Sa
PUT
$0
0
Q3 2024
New holding
Addus Homecare Corp
CALL
$0
0
Q3 2024
New holding
Addus Homecare Corp
PUT
$0
0
Q3 2024
New holding
Adecoagro S A
CALL
$0
0
Q3 2024
New holding
Adecoagro S A
PUT
$0
0
Q3 2024
New holding
Adeia Inc
CALL
$0
0
Q3 2024
New holding
Adeia Inc
PUT
$0
0
Q3 2024
New holding
Adial Pharmaceuticals Inc
CALL
$0
0
Q3 2024
New holding

Summary

  • Portfolio
  • No. of Stocks 22,037
  • Current Value $1.64 Billion
  • Prior Value $1.56 Billion
  • Filing
  • Period Q3 2024
  • Filing Date October 10, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 9,194 stocks
  • Additional Purchases 651 stocks
  • Sold out of 170 stocks
  • Reduced holdings in 988 stocks
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email